CCR6 and rheumatoid arthritis: Given the higher efficacy of anti-IL-17A in psoriatic arthritis [35–39], it would be of great interest to study differences in the induction of the pro-inflammatory feedforward loop by the CCR6+ memTh subpopulations between RA and PsA patients in future studies.